| # | Country | Total Patents | |
|---|---|---|---|
| #1 | United States | 6 | |
| #2 | Australia | 5 | |
| #3 | WIPO (World Intellectual Property Organization) | 5 | |
| #4 | Canada | 4 | |
| #5 | EPO (European Patent Office) | 4 | |
| #6 | Hong Kong | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Biotechnology | |
| #3 | Micro-structure and nano-technology |
| # | Technology | |
|---|---|---|
| #1 | Medical preparations | |
| #2 | Therapeutic chemical compounds | |
| #3 | Peptides | |
| #4 | Nanostructure applications |
| # | Name | Total Patents |
|---|---|---|
| #1 | Mascarenhas Desmond | 25 |
| #2 | Singh Baljit K | 3 |
| Publication | Filing date | Title |
|---|---|---|
| AU2005243741A1 | Methods for delivering MBD peptide- linked agent into cells under conditions of cellular stress | |
| US6914049B2 | IGF-binding protein-derived peptide or small molecule | |
| US6887851B2 | IGF-binding protein-derived peptide | |
| US6861406B2 | IGF-binding protein-derived peptide | |
| AU9109001A | Method for use of IGF-binding protein for selective sensitization of target cells in vivo |